Boothe Investment Group, Inc. Eli Lilly & CO Transaction History

Boothe Investment Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$724.87 - $909.04 $101,481 - $127,265	140 Added 3.41%	4,250 $3.89 Million
Q1 2024 Apr 30, 2024	SELL	$592.2 - $792.28 $3.26 Million - $4.36 Million	-5,505 Reduced 57.25%	4,110 $3.2 Million
Q4 2023 Jan 29, 2024	SELL	$525.19 - $619.13 $89,807 - $105,871	-171 Reduced 1.75%	9,615 $5.61 Million
Q3 2023 Oct 30, 2023	SELL	$434.7 - $599.3 $1.12 Million - $1.54 Million	-2,568 Reduced 20.79%	9,786 $5.26 Million
Q2 2023 Jul 17, 2023	BUY	$350.74 - $468.98 $5,962 - $7,972	17 Added 0.14%	12,354 $5.79 Million
Q1 2023 Apr 13, 2023	BUY	$310.63 - $364.82 $3.83 Million - $4.5 Million	12,337 New	12,337 $4.24 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Boothe Investment Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Boothe Investment Group, Inc. with notifications on news.